Insider Buy/Sell Details for the Biotechnology Industry — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1119)
Quantum-Si Inc (QSI)
Dowdy Paula — Director
Shares
109,890
Price
$0.95
Total Value
$104.45K
Shares Held After
269,107
% of Holdings
40.8%
PTC THERAPEUTICS, INC. (PTCT)
Golden Lee Scott — EVP & CHIEF MEDICAL OFFICER
Shares
10,000
Price
$63.38
Total Value
$633.80K
Shares Held After
79,944
% of Holdings
11.1%
Entera Bio Ltd. (ENTX)
Ellis Sean — Director
Shares
10,000
Price
$1.23
Total Value
$12.30K
Shares Held After
188,098
% of Holdings
5.3%
ADMA BIOLOGICS, INC. (ADMA)
ELMS STEVE — Director
Shares
7,000
Price
$15.67
Total Value
$109.69K
Shares Held After
2,038,730
% of Holdings
0.3%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Hamilton James C — Chief Medical Officer
Shares
10,000
Price
$64.19
Total Value
$641.90K
Shares Held After
236,958
% of Holdings
4.0%
NewAmsterdam Pharma Co N.V. (NAMS)
Kastelein Johannes Jacob Pieter — Director
Shares
104,467
Price
$30.30
Total Value
$3.17M
Shares Held After
69,302
% of Holdings
60.1%
Adaptive Biotechnologies Corp (ADPT)
LO FRANCIS — Chief People Officer
Shares
38,074
Price
$15.09
Total Value
$574.54K
Shares Held After
321,967
% of Holdings
10.6%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
1,786
Price
$18.74
Total Value
$33.46K
Shares Held After
339,392
% of Holdings
0.5%
Sionna Therapeutics, Inc. (SION)
Fitzpatrick Jennifer — Chief Legal Officer
Shares
10,250
Price
$33.86
Total Value
$347.02K
Shares Held After
0
% of Holdings
100.0%
Dyne Therapeutics, Inc. (DYN)
Kerr Douglas — Chief Medical Officer
Shares
904
Price
$14.90
Total Value
$13.47K
Shares Held After
171,606
% of Holdings
0.5%
Dyne Therapeutics, Inc. (DYN)
Cox John — Director
Shares
2,732
Price
$14.90
Total Value
$40.71K
Shares Held After
374,145
% of Holdings
0.7%
ProMIS Neurosciences Inc. (PMN)
Williams Eugene — Director
Shares
2,000
Price
$24.40
Total Value
$48.80K
Shares Held After
12,397
% of Holdings
16.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
30,941
Price
$16.00
Total Value
$495.06K
Shares Held After
575,235
% of Holdings
5.1%
ProMIS Neurosciences Inc. (PMN)
Williams Eugene — Director
Shares
2,000
Price
$24.00
Total Value
$48.00K
Shares Held After
10,397
% of Holdings
19.2%
FibroBiologics, Inc. (FBLG)
O'HEERON PETE — Director
Shares
15,872
Price
$0.38
Total Value
$6.01K
Shares Held After
5,958,147
% of Holdings
0.3%
Tarsus Pharmaceuticals, Inc. (TARS)
Neervannan Seshadri — Chief Operating Officer
Shares
8,366
Price
$76.67
Total Value
$641.42K
Shares Held After
70,817
% of Holdings
10.6%
Edesa Biotech, Inc. (EDSA)
Nijhawan Pardeep — Director
Shares
10,000
Price
$4.26
Total Value
$42.56K
Shares Held After
392,702
% of Holdings
2.5%
Tectonic Therapeutic, Inc. (TECX)
McNamara Peter — Chief Scientific Officer
Shares
1,650
Price
$25.00
Total Value
$41.25K
Shares Held After
58,832
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$497.05
Total Value
$19.88K
Shares Held After
130
% of Holdings
23.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$495.78
Total Value
$237.98K
Shares Held After
170
% of Holdings
73.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
215
Price
$494.74
Total Value
$106.37K
Shares Held After
650
% of Holdings
24.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
185
Price
$493.40
Total Value
$91.28K
Shares Held After
865
% of Holdings
17.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
243
Price
$492.44
Total Value
$119.66K
Shares Held After
1,050
% of Holdings
18.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
485
Price
$491.33
Total Value
$238.30K
Shares Held After
1,293
% of Holdings
27.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,808
Price
$490.52
Total Value
$886.86K
Shares Held After
1,778
% of Holdings
50.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,290
Price
$489.68
Total Value
$1.12M
Shares Held After
3,586
% of Holdings
39.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,429
Price
$488.63
Total Value
$1.19M
Shares Held After
5,876
% of Holdings
29.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
926
Price
$487.55
Total Value
$451.47K
Shares Held After
8,305
% of Holdings
10.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
399
Price
$486.42
Total Value
$194.08K
Shares Held After
9,231
% of Holdings
4.1%
EyePoint, Inc. (EYPT)
Ribeiro Ramiro — Chief Medical Officer
Shares
2,438
Price
$17.87
Total Value
$43.57K
Shares Held After
0
% of Holdings
100.0%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
35,710
Price
$19.32
Total Value
$689.83K
Shares Held After
964,161
% of Holdings
3.6%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
14,290
Price
$18.78
Total Value
$268.32K
Shares Held After
999,871
% of Holdings
1.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
57
Price
$325.67
Total Value
$18.56K
Shares Held After
21,227
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
75
Price
$324.88
Total Value
$24.37K
Shares Held After
21,284
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
210
Price
$323.84
Total Value
$68.01K
Shares Held After
21,359
% of Holdings
1.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
96
Price
$323.01
Total Value
$31.01K
Shares Held After
21,569
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
79
Price
$321.82
Total Value
$25.42K
Shares Held After
21,665
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
59
Price
$320.81
Total Value
$18.93K
Shares Held After
21,744
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
28
Price
$320.01
Total Value
$8.96K
Shares Held After
21,803
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
29
Price
$319.03
Total Value
$9.25K
Shares Held After
21,831
% of Holdings
0.1%
uniQure N.V. (QURE)
KLEMT CHRISTIAN — Chief Financial Officer
Shares
12,000
Price
$9.06
Total Value
$108.72K
Shares Held After
226,581
% of Holdings
5.0%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
German Christopher Paul — Corporate Controller & CAO
Shares
5,614
Price
$89.56
Total Value
$502.79K
Shares Held After
160
% of Holdings
97.2%
PepGen Inc. (PEPG)
McArthur James G — Director
Shares
131
Price
$6.33
Total Value
$828.58
Shares Held After
296,326
% of Holdings
0.0%
PepGen Inc. (PEPG)
McArthur James G — Director
Shares
5,144
Price
$6.23
Total Value
$32.05K
Shares Held After
296,457
% of Holdings
1.7%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
McKechnie Duncan — EVP, Chief Commercial Officer
Shares
2,437
Price
$475.30
Total Value
$1.16M
Shares Held After
15,122
% of Holdings
13.9%
PepGen Inc. (PEPG)
Donnelly Noel — Chief Financial Officer
Shares
52
Price
$6.33
Total Value
$328.90
Shares Held After
111,603
% of Holdings
0.0%
PepGen Inc. (PEPG)
Donnelly Noel — Chief Financial Officer
Shares
2,032
Price
$6.23
Total Value
$12.66K
Shares Held After
111,655
% of Holdings
1.8%
VERACYTE, INC. (VCYT)
Stapley Marc — Director
Shares
26,279
Price
$36.28
Total Value
$953.37K
Shares Held After
357,554
% of Holdings
6.8%
VERACYTE, INC. (VCYT)
Stapley Marc — Director
Shares
19,244
Price
$35.56
Total Value
$684.23K
Shares Held After
383,833
% of Holdings
4.8%
VERACYTE, INC. (VCYT)
Leite John — Chief Commercial Officer-CLIA
Shares
5,260
Price
$35.19
Total Value
$185.08K
Shares Held After
107,580
% of Holdings
4.7%
Showing 601–650 of 1119 transactions (page 13 of 23)